Aap Implantate AG (ETR:AAQ) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Aap Implantate AG

BRIEF

published on 12/04/2025 at 13:12, 15 hours 22 minutes ago

Aap Implantate AG Executes Cash Capital Increase

Private Placement New Shares Equity Base Cash Capital Increase Aap Implantate AG
PRESS RELEASE

published on 12/04/2025 at 13:07, 15 hours 27 minutes ago

EQS-Adhoc: aap Implantate AG: Cash capital increase
aap Implantate AG announces cash capital increase to strengthen equity base by issuing new shares with private placement to selected investors

Private Placement New Shares Equity Base Cash Capital Increase Aap Implantate AG
BRIEF

published on 10/28/2025 at 08:05, 1 month 7 days ago

Aap Implantate AG Reports Strong Growth in Q3 2025

Revenue Increase Sales Growth Global Markets Q3 Performance LOQTEQ® Portfolio
PRESS RELEASE

published on 10/28/2025 at 08:00, 1 month 7 days ago

aap Implantate AG reports strong growth in Q3/2025: +15%
aap Implantate AG reports 15% sales growth in Q3/2025 despite production challenges. LOQTEQ(R) plates gain popularity, driving revenue in all regions

Sales Growth Market Expansion Aap Implantate AG Q3 2025 LOQTEQ(R) Plates
BRIEF

published on 09/19/2025 at 22:05, 2 months 15 days ago

Aap Implantate AG Extends CEO Tenure and Announces COO Departure

Strategic Transformation Antibacterial Technology COO Resignation Aap CEO Silver Products
PRESS RELEASE

published on 09/19/2025 at 22:00, 2 months 15 days ago

aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
CEO Rubino Di Girolamo extends contract at aap Implantate AG until 2028; COO Agnieszka Mierzejewska to leave in 2025. Company focuses on new antibacterial technology and strategic realignment

COO CEO Aap Implantate AG Rubino Di Girolamo Agneiszka Mierzejewska
BRIEF

published on 09/16/2025 at 10:05, 2 months 18 days ago

Aap Implantate AG Reports €6.2 Million in Sales for H1 2025

Future Prospects Regional Growth US Tariff Impact H1 2025 Sales Clinical Trial Progress
PRESS RELEASE

published on 09/16/2025 at 10:00, 2 months 18 days ago

aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
aap Implantate AG reports €6.2 million sales in the first half of 2025, with clinical trial near positive conclusion. Regional growth in EMEA, strong performance in APAC, US tariff impact mitigated

Sales Clinical Trial Aap Implantate AG US Tariffs Regional Growth
BRIEF

published on 09/09/2025 at 15:05, 2 months 25 days ago

Aap Implantate AG Completes Clinical Trial for Antibacterial Technology

Investment Opportunities Clinical Trial Regulatory Approvals Healthcare Savings Antibacterial Technology
PRESS RELEASE

published on 09/09/2025 at 15:00, 2 months 25 days ago

aap successfully completes human clinical trial for antibacterial surface technology
aap Implantate AG successfully completes human clinical trial for antibacterial surface technology with positive results, expecting MDR and US FDA approval. Study report due by end of 2025

Clinical Trial Aap Implantate AG Antibacterial Surface Technology MDR Approval US FDA Approval

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 1 hour 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 3 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 4 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 9 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 19 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 24 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 10 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 49 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 50 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 33 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE